Tumor-derived parathyroid hormone-related peptide (PTHrP) drives myeloid cell recruitment via osteoblast-produced chemokine (C-C motif) ligand 2 (CCL2), which is high in the bone microenvironment and whose levels are associated with poor prognoses in primary breast tumors [14]. The gene discussed is CCL2; the disease is breast neoplasm.